About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

Luye Pharma’s Class 1 Innovative Antidepressant Targeting NET/DAT/GABAAR Approved for Clinical Trials in China

News

Shanghai, November 11, 2024 - Luye Pharma Group today announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved its Investigational New Drug (IND) application for LY03021 for ...

November 11,2024

Luye Pharma Announces 2024 Half Year Results

- Strong net profit growth: 201% - - ​Five new drugs approved for marketing - Shanghai, August 28, 2024 -- Luye Pharma Group today announced its 2024 half-year results and latest developments. During the reporting period, the total ...

August 29,2024

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company